Article
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon.
The Journal of infectious diseases - 1 Aug 2000
Polyak S J, Nousbaum J B, Larson A M, Cotler S, Carithers R L, Gretch D R
Abstract excerpt
The hepatitis C virus (HCV) envelope glycoprotein-2 inhibits the interferon (IFN)-induced, double-stranded RNA-activated protein kinase (PKR) via the PKR eukaryotic initiation factor-2alpha phosphorylation homology domain (PePHD). The present study examined the genetic variability of the PePHD in patients receiving IFN therapy. The PePHD from 12 HCV genotype 1 (HCV-1)-infected patients receiving daily IFN therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
